LFCR (Lifecore Biomedical) Total Current Assets: $77.64 Mil (As of Mar. 2026)

What is Lifecore Biomedical Total Current Assets?

Lifecore Biomedical LFCR -2.11% 55 Total Current Assets is $77.64 Mil as of Mar. 2026. GuruFocus rates LFCR with a GF Score™ of 55/100 and a GF Value™ of $6.52 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Lifecore Biomedical's total current assets for the quarter that ended in Mar. 2026 was $77.64 Mil.

Lifecore Biomedical (NAS:LFCR) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Lifecore Biomedical's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	20.795	-	253.937	+	0.75 * 19.437	+	0.5 * 28.155
=	-204.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical Total Current Assets Related Terms

Lifecore Biomedical Total Current Assets Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's Total Current Assets can be seen below:

Lifecore Biomedical Total Current Assets Chart

Lifecore Biomedical Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

May25

Total Current Assets

Get a 7-Day Free Trial

148.32

116.67

93.88

81.03

85.68

Lifecore Biomedical Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Sep25	Dec25	Mar26
Total Current Assets	Get a 7-Day Free Trial															84.21	85.68	83.93	82.29	77.64

55GF Score

Lifecore Biomedical Inc LFCR

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lifecore Biomedical Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Lifecore Biomedical's Total Current Assets for the fiscal year that ended in May. 2025 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	8.265	+	43.667	+	32.291	+	1.454
	=	85.68

Lifecore Biomedical's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	20.795	+	26.886	+	28.155	+	1.803
	=	77.64

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of $77.64 Mil mean?

Lifecore Biomedical (LFCR) has a Total Current Assets of $77.64 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Lifecore Biomedical and its competitors.

Is Lifecore Biomedical's Total Current Assets too high?

Lifecore Biomedical's current Total Current Assets is $77.64 Mil. Overall, Lifecore Biomedical has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Lifecore Biomedical's Total Current Assets compare to ANIK and DERM?

Lifecore Biomedical's Total Current Assets of $77.64 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Drug Manufacturers company?

A good Total Current Assets depends on the Drug Manufacturers industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Lifecore Biomedical and its competitors. Lifecore Biomedical's current Total Current Assets is $77.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lifecore Biomedical stock overvalued right now?

Based on GuruFocus' analysis, Lifecore Biomedical (LFCR) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.52, compared to a current price of $4.87 — trading 25.4% below its estimated fair value. The current Total Current Assets is $77.64 Mil. Lifecore Biomedical's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For Lifecore Biomedical (LFCR), the current Total Current Assets is $77.64 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (LFCR) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of $4.87 is trading 25.4% below its estimated GF Value™ of $6.52. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for LFCR:

Total Current Assets: $77.64 Mil
GF Value™: $6.52 vs. price of $4.87 (25.4% below fair value)
GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LFCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lifecore Biomedical Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ANIK DERM ASRT SIGA CPIX AKBA TKNO ORGO INCR CTOR XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges LDE:Germany

Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318

Website https://www.lifecore.com

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

55GF Score

Get the complete analysis for LFCR

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.87

Price

$6.52

GF Value

View LFCR Analysis

See Total Current Assets data for all stocks →